Companies/BBS-Bioactive Bone Substitutes Oyj
Follow

BBS-Bioactive Bone Substitutes Oyj

Nasdaq First North GM Helsinki (Finland)

Bioactive Bone Substitutes is a health technology company, that develops, designs and manufactures innovative bioactive bone-graft substitute implants. Its ortho biological product ARTEBONE, which is based on tricalcium phosphate (TCP) and natural spectrum of bone proteins has the capability of bone regeneration.
Go to market

Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Media
Showing 3 of 4
View all
www.bbs-artebone.fi
Current instruments
Type
Ticker
ISIN
SHARE
BONEH
FI4000260583
Nasdaq First North GM Helsinki Finland (FI)
Top
News
BBS:n hallituksen puheenjohtaja: Tuoteluokituspäätös tärkeä virstanpylväs yhtiön matkalla kohti CE-merkintää
29 May 2023 - 14:45
BBS-Bioactive Bone Substitutes Plc – Inside information – Positive decision received on the product classification, schedule for the quality system approval to be updated
26 May 2023 - 16:30
BBS-Bioactive Bone Substitutes Oyj – Sisäpiiritieto - ARTEBONE® Pasten tuoteluokituksesta positiivinen päätös, laatujärjestelmäprosessin aikataulua tullaan päivittämään
26 May 2023 - 16:30
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
22 May 2023 - 15:00
BBS-Bioactive Bone Substitutes Oyj: BBS:n ja Riverfort Global Opportunities PCC Ltd:n väliseen rahoitusjärjestelyyn liittyvä vaihtovelkakirjalainojen vaihtaminen osakkeiksi
22 May 2023 - 15:00
BBS-Bioactive Bone Substitutes Oyj: The subscription period for the second warrant series starts on 22 May 2023 – the subscription price is EUR 0.65 per share
19 May 2023 - 11:00
BBS-Bioactive Bone Substitutes Oyj: Toisen optiosarjan merkintäaika alkaa 22.5.2023 – merkintähinta on 0,65 euroa osakkeelta
19 May 2023 - 11:00
BBS-Bioactive Bone Substitutes Plc: Fimea has conducted a regular periodic audit regarding the company's pharmaceutical factory permit
17 May 2023 - 18:00
BBS-Bioactive Bone Substitutes Oyj: Fimea on suorittanut säännöllisen määräaikaisen tarkastuksen yhtiön lääketehdaslupaan liittyen
17 May 2023 - 18:00
BBS-Bioactive Bone Substitutes Plc has renewed a capital facility with RiverFort Global Opportunities PCC
31 Mar 2023 - 18:45
1 2 3 4 5
Show

10

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
BONES
FI4000260583
Details of share in BBS-Bioactive Bone Substitutes Oyj with ticker BONES
Status
Active
Currency
SEK
First trading date
28 Feb 2018
Distribution issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Delisting
Sign in to buy
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
BONEH
FI4000260583
Nasdaq First North GM Helsinki
Finland (FI)
Details of share in BBS-Bioactive Bone Substitutes Oyj with ticker BONEH
Status
Active
Currency
EUR
First trading date
28 Feb 2018
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
BONES
FI4000260583
Details of share in BBS-Bioactive Bone Substitutes Oyj with ticker BONES
Status
Delisted
Currency
SEK
First trading date
28 Feb 2018
Distribution issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Delisting
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
BONEH
FI4000260583
Nasdaq First North GM Helsinki
Finland (FI)
Details of share in BBS-Bioactive Bone Substitutes Oyj with ticker BONEH
Status
Active
Currency
EUR
First trading date
28 Feb 2018
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
BONEH TO1
FI4000522891
Nasdaq First North GM Helsinki
Finland (FI)
Details of option in BBS-Bioactive Bone Substitutes Oyj with ticker BONEH TO1
Status
Archived
Currency
EUR
Trading period
01 Jul 2022 - 30 Nov 2022
Terms
One (1) warrant TO1 entitles the holder to subscribe for one (1) new share with a subscription price that will be decided based on the volume weighted average price of the Company’s shares in First North Growth Market Finland for eight (8) trading days prior to the warrant’s share subscription period with a 25% discount.
Update (28.06.2022): First trading day for warrants TO1 is July 1, 2022.
Update (18.11.2022): Subscription price for warrants TO1 has been set - EUR 0.92 per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
BONEH TO2
FI4000522909
Nasdaq First North GM Helsinki
Finland (FI)
Details of option in BBS-Bioactive Bone Substitutes Oyj with ticker BONEH TO2
Status
Archived
Currency
SEK
Trading period
01 Jul 2022 - 30 May 2023
Terms
One (1) warrant TO1 entitles the holder to subscribe for one (1) new share with a subscription price that will be decided based on the volume weighted average price of the Company’s shares in First North Growth Market Finland for eight (8) trading days prior to the warrant’s share subscription period with a 25% discount.
Update (28.06.2022): First trading day for warrants TO2 is July 1, 2022.
Update (19.05.2023): Subscription price for warrants TO2 has been set - SEK 0.65 per share.
Exercise
Sign in to buy
People
Ilkka Kangasniemi
CEO
Jarmo Olavi Halonen
Chairman of the board
Pekka Jalovaara
Board member
Seppo Nevalainen
Board member
Kirk Andriano
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Kiviharjunlenkki 6
Zip code
902 20
City/district
Oulu
Country
Finland (FI)
Phones
Email
[email protected]
Registration number
0866451-4
LEI code
743700BYSBP0PCR6N767
First trade date
28 Feb 2018
Registration date
22 Nov 1991
Short name
BONES

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More